Dominic A. Siler

Dominic A. Siler

Auto-generated profile, based on publicly available information

Dominic A. Siler

Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Women's Health
Verified
Journal Article
Open access
Catherine DavisCatherine Davis
Catherine Davis
DSDominic A Siler
Dominic A Siler
NANabil Alkayed
Nabil Alkayed
The endothelial layer of cells lining the intimal surface of blood vessels is essential for vascular function. The endothelium releases multiple vasodilator and protective factors, including nitric oxide, prostacyclin and endothelium-derived hyperpolarizing factor; an imbalance in these factors predisposes individuals to vascular diseases such as stroke. These factors are differentially regulated by vessel size, sex hormones and disease state, therefore playing differential roles in different tissues following vascular injury. In particular, the endothelium-derived hyperpolarizing factor candidate termed epoxyeicosatrienoic acid, plays a prominent role in microvessel function, especially after ischemia, thereby making this signaling pathway an attractive target for therapy in vascular disease, including stroke.

25 June 2022 in Neuro-Oncology Advances
Verified
Journal Article
Open access
PDF file
KUKutluay Uluc
Kutluay Uluc
PAPrakash Ambady
Prakash Ambady
MMMatthew K McIntyre
Matthew K McIntyre
JTJohn Philip Tabb
John Philip Tabb
CKCymon N Kersch
Cymon N Kersch
ENEdward A Neuwelt
Edward A Neuwelt
Intra-arterial administration of chemotherapy with or without osmotic blood–brain barrier disruption enhances delivery of therapeutic agents to brain tumors. The aim of this study is to evaluate the safety of these procedures. Retrospectively collected data from a prospective database of consecutive patients with primary and metastatic brain tumors who received intra-arterial chemotherapy without osmotic blood–brain barrier disruption (IA) or intra-arterial chemotherapy with osmotic blood–brain barrier disruption (IA/OBBBD) at Oregon Health and Science University (OHSU) between December 1997 and November 2018 is reported. Chemotherapy-related complications are detailed per Common Terminology Criteria for Adverse Events (CTCAE) guidelines. Procedure-related complications are grouped as major and minor. 4939 procedures (1102 IA; 3837 IA/OBBBD) were performed on 436 patients with various pathologies (primary central nervous system lymphoma [26.4%], glioblastoma [18.1%], and oligodendroglioma [14.7%]). Major procedure-related complications (IA: 12, 1%; IA/OBBBD: 27, 0.7%; P = .292) occurred in 39 procedures including 3 arterial dissections requiring intervention, 21 symptomatic strokes, 3 myocardial infarctions, 6 cervical cord injuries, and 6 deaths within 3 days. Minor procedure-related complications occurred in 330 procedures (IA: 41, 3.7%; IA/OBBBD: 289, 7.5%; P = .001). Chemotherapy-related complications with a CTCAE attribution and grade higher than 3 was seen in 359 (82.3%) patients. We provide safety and tolerability data from the largest cohort of consecutive patients who received IA or IA/OBBBD. Our data demonstrate that IA or IA/OBBBD safely enhance drug delivery to brain tumors and brain around the tumor.

1 November 2022 in Operative Neurosurgery
Verified
Journal Article
Closed access
DSDominic A. Siler
Dominic A. Siler
DCDaniel R. Cleary
Daniel R. Cleary
KTKaren J. Tonsfeldt
Karen J. Tonsfeldt
AWArvin R. Wali
Arvin R. Wali
HHHolly E. Hinson
Holly E. Hinson
NSNathan R. Selden
Nathan R. Selden
BACKGROUND: Systematic use of neurosurgical training simulators across institutions is significantly hindered by logistical and financial constraints. OBJECTIVE: To evaluate feasibility of large-scale implementation of an intraoperative catastrophe simulation, we introduced a highly portable and low-cost immersive neurosurgical simulator into a nationwide curriculum for neurosurgery residents, during years 2016 to 2019. METHODS: The simulator was deployed at 9 Society of Neurological Surgeons junior resident courses and a Congress of Neurological Surgeons education course for a cohort of 526 residents. Heart rate was tracked to monitor physiological responses to simulated stress. Experiential survey data were collected to evaluate simulator fidelity and resident attitudes toward simulation. RESULTS: Residents rated the simulator positively with a statistically significant increase in satisfaction over time accompanying refinements in the simulator model and clinical scenario. The simulated complications induced stress-related tachycardia in most participants (n = 249); however, a cohort of participants was identified that experienced significant bradycardia (n = 24) in response to simulated stress. CONCLUSION: Incorporation of immersive neurosurgical simulation into the US national curriculum is logistically feasible and cost-effective for neurosurgical learners. Participant surveys and physiological data suggest that the simulation model recreates the situational physiological stress experienced during practice in the live clinical environment. Simulation may provide an opportunity to identify trainees with maladaptive responses to operative stress who could benefit from additional simulated exposure to mitigate stress impacts on performance.

1 December 2022 in Brain Hemorrhages
Verified
Journal Article
Open access
DSDominic A. Siler
Dominic A. Siler
ASAlexa M. Semonche
Alexa M. Semonche
RSRavi Samatham
Ravi Samatham
JLJesse J. Liu
Jesse J. Liu
RMRoss P. Martini
Ross P. Martini
JCJustin S. Cetas
Justin S. Cetas

19 November 2024 in Advanced Neurology
Verified
Journal Article
Open access
PDF file
TSTaylor C. Stevenson
Taylor C. Stevenson
MSMaryam N. Shahin
Maryam N. Shahin
DSDominic A. Siler
Dominic A. Siler
EYErin A Yamamoto
Erin A Yamamoto
CRChristian G. Lopez Ramos
Christian G. Lopez Ramos
DRDonald A. Ross
Donald A. Ross
Diagnosing shunt patency is crucial in the neurosurgical care of patients with shunted hydrocephalus. The shuntogram is a commonly used method to assess patency, yet its utility in accurately diagnosing shunt failure remains inconsistent. In this article, we examined studies on shuntograms performed in patients with fixed-pressure valves to clarify the techniques used and establish criteria for interpretation. We further reviewed conflicting evidence in the literature regarding the utility of shuntograms and outlined our institution’s protocol in the context of programmable valves. Studies included in this review detailed the following elements of shuntogram techniques: patient age, indication for shunt failure assessment, positioning, skin preparation, imaging protocol, contrast agents, patency testing, criteria for negative and positive results, troubleshooting shunt, and sensitivity and specificity of findings. Selection criteria included vague symptoms of shunt malfunction in the presence of non-diagnostic imaging. Patients were typically positioned supine or recumbent, with skin prepared using iodine-based products. Shunts were accessed using a 23 – 25-gauge needle, observing cerebrospinal fluid pressure and aspirate. The contrast agent most frequently used was 99mTc-diethylene-triamine-pentaacetate, although the exact volume injected was inconsistently reported. Imaging protocols were not standardized, with delayed imaging intervals usually ranging from 9 to 20 min. Failure criteria for shuntograms varied significantly, with limited guidance on follow-up interventions or troubleshooting. Notably, there was no mention of shunt reprogramming during these studies. This review highlights the significant variability in shuntogram techniques and outcomes. We present our institution’s protocol and a case scenario demonstrating successful implementation. With proper techniques and protocolization, shuntograms hold the potential as a valuable resource for accurately diagnosing shunt patency.

1 March 2023 in Brain Hemorrhages
Verified
Journal Article
Open access
DSDominic A. Siler
Dominic A. Siler
KRKate U. Rosen
Kate U. Rosen
SBStephen G. Bowden
Stephen G. Bowden
APAndrew Y. Powers
Andrew Y. Powers
JLJesse J. Liu
Jesse J. Liu
JCJustin S. Cetas
Justin S. Cetas